Observational study of Sativex in patients with multiple sclerosis-related spasticity.

Trial Profile

Observational study of Sativex in patients with multiple sclerosis-related spasticity.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2014

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Multiple sclerosis; Muscle spasticity
  • Focus Therapeutic Use
  • Acronyms MOVE-2
  • Most Recent Events

    • 24 Oct 2012 New trial record
    • 12 Oct 2012 Results were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in October 2012.
    • 12 Oct 2012 A cost-effectiveness analysis has been conducted using data from this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top